← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Pres, Chief Res, Dev Officer Robert Coffin sold $413K of Replimune Group, Inc.

Sold$413,220
$17.04Price
24,250Shares
−1%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Feb 20. Filed Mon, Feb 24, 11:02 AM ET, during the session. Not investment advice.